Consistently, I3A treatment significantly increased the presence of tumor‐infiltrating CD8+ T cells in B16 tumors, concomitant with an elevated level of GZMB expression on these infiltrated cells (Figure S4H, Supporting Information), suggesting immune activation in the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.